Tetsuhei Ogawa

815 total citations
35 papers, 654 citations indexed

About

Tetsuhei Ogawa is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Tetsuhei Ogawa has authored 35 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Epidemiology. Recurrent topics in Tetsuhei Ogawa's work include Acute Myeloid Leukemia Research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Nutritional Studies and Diet (4 papers). Tetsuhei Ogawa is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Nutritional Studies and Diet (4 papers). Tetsuhei Ogawa collaborates with scholars based in Japan, Netherlands and Pakistan. Tetsuhei Ogawa's co-authors include Norihito Watanabe, Shohei Matsuzaki, Seiichiro Kojima, Makoto Numata, Hayato Miyachi, Hiroyuki Kobayashi, Henk K. Koerten, Walter Daems, Yuzuru Takemura and Y. Tsuzuki and has published in prestigious journals such as Stroke, Cell and Tissue Research and Alcoholism Clinical and Experimental Research.

In The Last Decade

Tetsuhei Ogawa

32 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuhei Ogawa Japan 10 367 217 132 116 116 35 654
J. R. Jonsson Australia 13 312 0.9× 256 1.2× 259 2.0× 196 1.7× 57 0.5× 27 869
Anna Verrone Italy 15 381 1.0× 144 0.7× 115 0.9× 89 0.8× 224 1.9× 32 749
Fabian Kütting Germany 10 394 1.1× 178 0.8× 137 1.0× 175 1.5× 90 0.8× 26 728
Ursula Huber-Schönauer Austria 14 502 1.4× 257 1.2× 187 1.4× 80 0.7× 202 1.7× 30 697
D. Ganazzi Italy 9 453 1.2× 194 0.9× 176 1.3× 135 1.2× 193 1.7× 13 658
Kenichiro Seki Japan 15 307 0.8× 157 0.7× 132 1.0× 145 1.3× 68 0.6× 37 732
Smruti R. Mohanty United States 12 577 1.6× 169 0.8× 263 2.0× 158 1.4× 67 0.6× 34 769
Yoshihiro Kanbara Japan 13 436 1.2× 119 0.5× 297 2.3× 111 1.0× 68 0.6× 30 739
İbrahim Hatemı Türkiye 15 286 0.8× 100 0.5× 88 0.7× 141 1.2× 56 0.5× 78 720
S.G. Hübscher United Kingdom 10 327 0.9× 93 0.4× 250 1.9× 210 1.8× 95 0.8× 27 583

Countries citing papers authored by Tetsuhei Ogawa

Since Specialization
Citations

This map shows the geographic impact of Tetsuhei Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhei Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhei Ogawa more than expected).

Fields of papers citing papers by Tetsuhei Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhei Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhei Ogawa. The network helps show where Tetsuhei Ogawa may publish in the future.

Co-authorship network of co-authors of Tetsuhei Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhei Ogawa. A scholar is included among the top collaborators of Tetsuhei Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhei Ogawa. Tetsuhei Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishizaki, Yasuhiro, Akira KUBO, Ichiro Kuwahira, et al.. (2012). Anti-aging health check-up system:— For the prevention of potentially progress aging related disadvantageous changes in elderly —. 39(4). 549–557. 9 indexed citations
2.
3.
Miura, Soichiro, Y. Tsuzuki, Ryota Hokari, et al.. (2005). Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis. Clinical & Experimental Immunology. 139(3). 421–428. 50 indexed citations
4.
Nishizaki, Yasuhiro, Hiroyuki Nakamura, Fuminori Kobayashi, et al.. (2003). Hemophagocytic syndrome in ileum-origin B-cell lymphoma. Journal of Gastroenterology. 38(10). 995–999. 1 indexed citations
5.
Yokoyama, Hirokazu, Susumu Moriya, Yasuhiko Homma, & Tetsuhei Ogawa. (2003). Association Between γ‐Glutamyl Transpeptidase Activity and Status of Disorders Constituting Insulin Resistance Syndrome. Alcoholism Clinical and Experimental Research. 27(s1). 22S–25S. 10 indexed citations
6.
Kojima, Seiichiro, Norihito Watanabe, Makoto Numata, Tetsuhei Ogawa, & Shohei Matsuzaki. (2003). Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. Journal of Gastroenterology. 38(10). 954–961. 377 indexed citations
7.
Ogawa, Tetsuhei, Kenichi Maruyama, H. Hattori, et al.. (2000). A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy. Pediatric Nephrology. 14(2). 149–151. 34 indexed citations
8.
Yuan, Ping, Yoichi Ogushi, Yoshikazu Okada, et al.. (1998). Lifestyle and colorectal cancer: A case-control study. Environmental Health and Preventive Medicine. 3(3). 146–151. 13 indexed citations
9.
Ogawa, Tetsuhei. (1996). [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia].. PubMed. 37(7). 604–9. 1 indexed citations
10.
Toyama, Keisuke, Makoto Yaguchi, Kazunori Wakasugi, et al.. (1993). Clinical evaluation of combination therapy with tobramycin and ceftazidime for severe infections associated with hematological disorders. Chemotherapy. 41(8). 911–919. 1 indexed citations
11.
Hayashida, Tomoko, Yoshinori Araki, K Kawano, et al.. (1992). [Extramedullary diseases as presenting features of aleukemic acute monocytic leukemia].. PubMed. 33(11). 1679–84.
12.
Hagihara, Masao, Hiroyuki Kobayashi, Hayato Miyachi, & Tetsuhei Ogawa. (1991). Clinical Heterogeneity in Acute Myelogenous Leukemia with the 8;21 Translocation.. The Keio Journal of Medicine. 40(2). 90–93. 10 indexed citations
13.
Yano, Takahiro, et al.. (1990). In vitro endocytosis of benign and malignant human bone marrow plasma cells. American Journal of Hematology. 35(2). 100–103. 2 indexed citations
14.
Terashima, Takeshi, et al.. (1990). Prolymphocytic leukemia treated with natural and recombinant α‐interferon. American Journal of Hematology. 35(1). 56–58. 2 indexed citations
15.
Yano, Takahiro, et al.. (1990). Application of the avidin‐biotin‐peroxidase complex technique for ultraimmunocytochemical characterization of leukemic cells. American Journal of Hematology. 34(2). 140–148. 2 indexed citations
16.
Kobayashi, Hiroyuki, Hayato Miyachi, Tetsuhei Ogawa, & Masahito Jimbo. (1990). Translocation t(11;22)(q23;q11) in an adult with acute monoblastic leukemia.. Japanese Journal of Medicine. 29(5). 527–532. 2 indexed citations
17.
Kanno, Hitoshi, Hisaichi Fujii, Kenzaburo Tani, et al.. (1988). Elevated erythrocyte adenosine deaminase activity in a patient with primary acquired sideroblastic anemia. American Journal of Hematology. 27(3). 216–220. 6 indexed citations
18.
Kizaki, Masahiro, Tetsuhei Ogawa, Y Watanabe, & Keisuke Toyama. (1988). Spontaneous remission in hypoplastic acute leukemia.. The Keio Journal of Medicine. 37(3). 299–307. 9 indexed citations
19.
Ogawa, Tetsuhei, H.K. Koerten, P. Brederoo, & Walter Daems. (1983). A comparative study of primary and secondary granules in monocytopoiesis and myelopoiesis of mouse bone marrow. Cell and Tissue Research. 228(1). 107–15. 2 indexed citations
20.
Ogawa, Tetsuhei, et al.. (1977). [Studies of tobramycin eye drops. Report 2. Intraocular penetration (author's transl)].. PubMed. 81(11). 1777–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. R. Jonsson Breakdown of academic impact, for papers by Anna Verrone Breakdown of academic impact, for papers by Fabian Kütting Breakdown of academic impact, for papers by Ursula Huber-Schönauer Breakdown of academic impact, for papers by D. Ganazzi Breakdown of academic impact, for papers by Kenichiro Seki Breakdown of academic impact, for papers by Smruti R. Mohanty Breakdown of academic impact, for papers by Yoshihiro Kanbara Breakdown of academic impact, for papers by İbrahim Hatemı Breakdown of academic impact, for papers by S.G. Hübscher
Rankless by CCL
2026